Mynd.ai Faces Six-Month Cure Period After Missing May Deadline for 2025 Form 20-F
On May 18, 2026, Mynd.ai received an NYSE American notice for missing its May 15 filing deadline for the 2025 Form 20-F, triggering a six-month cure period before potential delisting. The company cited unresolved accounting judgments and is working with advisors to finalize the report.
1. NYSE Notice and Cure Timeline
On May 18, 2026, Mynd.ai received notice that it missed the May 15 deadline to file its annual Form 20-F for the year ended December 31, 2025, under Section 1007 of the NYSE American Company Guide. The notice initiates a six-month Initial Cure Period ending November 15, 2026, after which additional delisting procedures may begin if compliance is not regained.
2. Reasons for Filing Delay
The company filed a Form 12b-25 on April 30, 2026, attributing its late submission to delays in finalizing critical accounting judgments and disclosures in its 2025 financial statements. These issues required extensive review and consultation with external advisors to ensure accuracy.
3. Compliance and Remediation Efforts
Mynd.ai is working with its advisors and auditors to resolve outstanding accounting items and complete the Form 20-F. The company intends to file within the Initial Cure Period but has not provided assurance that all listing standards will be met in time.
4. Impact on Listing and Trading
There is no immediate effect on the trading of Mynd.ai’s American Depositary Shares, which will continue on the NYSE American. However, failure to file within the allowed periods could lead to suspension or delisting procedures.